Back to search

Article

Perceptions of persons deprived of liberty regarding tuberculosis vaccine research

2025-07-06

Abstract excerpt

<h4>Background: </h4> Several tuberculosis (TB) vaccine candidates are currently advancing to late stage clinical trials. Prisons in low- and middle-income countries harbor some of the highest rates of TB in the world, making persons deprived of liberty (PDL) an important population to prioritize for the introduction of effective vaccines. However, their inclusion in clinical trials raises significant ethical conc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a975d50d-93e6-5a8b-949c-e9a2ac11133a
DOI
10.1101/2025.07.04.25330885
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Perceptions of persons deprived of liberty regarding tuberculosis vaccine researchDOI 10.1101/2025.07.04.25330885
Tuberculosis preventive treatment in a Brazilian prison: acceptability, completion, and perspectives of persons deprived of liberty and their family membersSemantic proximity
Building Up Facilitators, Breaking Down Barriers: A Scoping Review Mapping Factors that Impact Participation in Vaccine TrialsSemantic proximity
Prevalence and individual level enablers and barriers for COVID-19 vaccine uptake among adult tuberculosis patients attending selected clinics in Nairobi County, KenyaSemantic proximity
Acceptability of advanced Controlled Human Infection Models; the case of a pneumococcal challenge in people living with HIV and mycobacterial challenge with Bacillus Calmette Guerin in MalawiSemantic proximity
“Six months is a lot of time to lie”: Anticipated stigma, disclosure and treatment preferences among participants in a tuberculosis therapeutic trialSemantic proximity
Melioidosis Vaccines (MeVa): Attitudes to vaccines, melioidosis and clinical trials in key stakeholders in Ubon Ratchathani, ThailandSemantic proximity
Collection and use of human materials during TB clinical research; a review of practicesSemantic proximity
Ethical Acceptability of Human Challenge Trials: Consultation With the US Public and With Research PersonnelSemantic proximity
Tuberculosis treatment outcomes after transfer or release from incarceration: A retrospective cohort study from BrazilSemantic proximity
Engaging Vulnerable Populations Around mRNA Vaccines to Build Tailored Education and Improve Vaccine ConfidenceSemantic proximity
Patient acceptance of preventive antibiotic treatment for tuberculosis: a qualitative studySemantic proximity
Post-trial access practices in conducted clinical trials for Malaria, Tuberculosis, and Neglected Tropical Diseases (NTDs) across Sub-Saharan African countries: A quantitative studySemantic proximity
Select a neighboring publication to make it the new centre.